BlackRock Fund Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$37.8M Buy
8,524,295
+1,106,467
+15% +$4.64M 0.01% 1841
2016
Q3
$34.6M Buy
7,417,828
+1,439,851
+24% +$8.53M 0.01% 1809
2016
Q2
$39.3M Buy
5,977,977
+31,370
+0.5% +$222K 0.01% 1647
2016
Q1
$37.8M Buy
5,946,607
+8,121
+0.1% +$41.7K 0.01% 1622
2015
Q4
$35.8M Buy
5,938,486
+80,117
+1% +$458K 0.01% 1706
2015
Q3
$35M Sell
5,858,369
-130,152
-2% -$904K 0.01% 1648
2015
Q2
$41M Buy
5,988,521
+432,872
+8% +$2.75M 0.01% 1658
2015
Q1
$33.7M Buy
5,555,649
+202,807
+4% +$1.35M 0.01% 1771
2014
Q4
$37.1M Buy
5,352,842
+617,551
+13% +$4.54M 0.01% 1677
2014
Q3
$38.5M Buy
4,735,291
+122,127
+3% +$956K 0.01% 1533
2014
Q2
$37.5M Buy
4,613,164
+596,356
+15% +$4.52M 0.01% 1598
2014
Q1
$31.5M Sell
4,016,808
-313,153
-7% -$2.65M 0.01% 1735
2013
Q4
$38.3M Buy
4,329,961
+163,150
+4% +$1.46M 0.01% 1582
2013
Q3
$34.9M Buy
4,166,811
+528,968
+15% +$4.28M 0.01% 1588
2013
Q2
$27.1M Buy
+3,637,843
New +$27.9M 0.01% 1627

Other funds holding SPPI

BlackRock Fund Advisors's SPPI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 15% in Q4 2016, buying an estimated $4.64M and bringing the position to 8,524,295 shares worth $37.8M. The position accounts for 0.01% of the portfolio, ranked #1841.

BlackRock Fund Advisors first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $41M in Q2 2015. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.

  • BlackRock Fund Advisors held 8,524,295 shares of Spectrum Pharmaceuticals Inc worth $37.8M as of Q4 2016.
  • BlackRock Fund Advisors bought 1,106,467 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $4.64M.
  • Spectrum Pharmaceuticals Inc made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1841 holding.
  • BlackRock Fund Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Spectrum Pharmaceuticals Inc position peaked at $41M in Q2 2015.
  • 139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.